{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:05:55Z","timestamp":1794503155606,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["N01 MH-90003"],"award-info":[{"award-number":["N01 MH-90003"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Depression Research and Clinical Care"},{"DOI":"10.13039\/100012184","name":"Hersh Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012184","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.psyneuen.2017.01.023","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T20:21:52Z","timestamp":1485289312000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"special_numbering":"C","title":["Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial"],"prefix":"10.1016","volume":"78","author":[{"given":"Manish K.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi S.","family":"Gadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Grannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Soyombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn L.","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2017.01.023_bib0005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.2015.14020181","article-title":"Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial","volume":"172","author":"Arnow","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0010","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/mp.2012.197","article-title":"Elevated maternal C-reactive protein and autism in a national birth cohort","volume":"19","author":"Brown","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0020","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","article-title":"A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice","volume":"6","author":"Brustolim","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/dmd.115.068932","article-title":"Development of a rat plasma and brain extracellular fluid pharmacokinetic model for bupropion and hydroxybupropion based on microdialysis sampling, and application to predict human brain concentrations","volume":"44","author":"Cremers","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0030","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2011.150318","article-title":"The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses","volume":"71","author":"Ebbinghaus","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"2","key":"10.1016\/j.psyneuen.2017.01.023_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.hjr.0000114967.39211.e5","article-title":"Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study","volume":"11","author":"Emberson","year":"2004","journal-title":"Eur. J. Cardiovasc. Prev. Rehab."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.ajp.2015.15060788","article-title":"Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression","volume":"173","author":"Fawcett","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0065","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2016_13","article-title":"The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications","author":"Felger","year":"2016","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsych.2015.11.003","article-title":"The selective serotonin reuptake inhibitor citalopram decreases human immunodeficiency virus receptor and coreceptor expression in immune cells","volume":"80","author":"Greeson","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1beta: tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0080","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881109102770","article-title":"Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy","volume":"24","author":"Harley","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-1781(00)00184-0","article-title":"Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL\/6 mice","volume":"96","author":"Kubera","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0105","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1038\/tp.2016.115","article-title":"Serum proteomic profiles of depressive subtypes","volume":"6","author":"Lamers","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0110","article-title":"Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice","author":"Lieberknecht","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/ajp.151.1.112","article-title":"Haptoglobin phenotypes and gene frequencies in unipolar major depression","volume":"151","author":"Maes","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157015912800604542","article-title":"Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance","volume":"10","author":"Martino","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0125","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4088\/JCP.v69n1201","article-title":"Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report","volume":"69","author":"McGrath","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2016.01.020","article-title":"The role of dopamine in modulation of Th-17 immune response in multiple sclerosis","volume":"292","author":"Melnikov","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","article-title":"Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy","volume":"41","author":"O\u2019Brien","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0140","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0150","doi-asserted-by":"crossref","first-page":"e1428","DOI":"10.4088\/JCP.14m09009","article-title":"Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009\u20132010 National Health and Nutrition Examination Survey (NHANES)","volume":"75","author":"Rethorst","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0155","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/01.CIR.0000093381.57779.67","article-title":"Cardiology Patient Page: C-reactive protein: a simple test to help predict risk of heart attack and stroke","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.biopsych.2005.08.022","article-title":"An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report","volume":"59","author":"Rush","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0306-3623(94)90188-0","article-title":"Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis In vitro","volume":"25","author":"Sacerdote","year":"1994","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2015.14050680","article-title":"ABCB1 genetic effects on antidepressant outcomes: a report from the iSPOT-D trial","volume":"172","author":"Schatzberg","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0190","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpsychires.2015.09.001","article-title":"The pro-inflammatory profile of depressed patients is (partly) related to obesity","volume":"70","author":"Shelton","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2013.06.006","article-title":"Citalopram suppresses thymocyte cytokine production","volume":"262","author":"Shenoy","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0205","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1017\/S0033291712001742","article-title":"Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report","volume":"43","author":"Sung","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0215","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0220","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1038\/tp.2015.137","article-title":"Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression","volume":"5","author":"Verduijn","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0225","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0235","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"ELevated c-reactive protein levels, psychological distress, and depression in 73 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0240","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM200504143521525","article-title":"Distribution of C-reactive protein values in the United States","volume":"352","author":"Woloshin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2017.01.023_bib0245","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016310526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016310526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:19Z","timestamp":1759683319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016310526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"alternative-id":["S0306453016310526"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.01.023","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}